Russia declares cancer vaccine "ready for use"

The head of the FMBA said that Russia's anti-cancer vaccine has passed preclinical trials, meaning it is ready for use and is currently awaiting licensing.

The head of the Russian Federal Medical and Biological Agency (FMBA), former Health Minister Veronika Skvortsova, announced that the Russian anti-cancer vaccine has passed preclinical trials, meaning it is ready for use, and the agency is now waiting for the Ministry of Health to grant approval for clinical use.

FMBA submitted its application to the Ministry of Health late last summer.

Studies have demonstrated the vaccine's safety, including repeated use, and its high efficacy in terms of reducing the size and slowing the growth of tumors significantly (up to 60-80%), Ms. Skvortsova said.

Additionally, studies have shown increased survival rates, which is also very important.

According to Ms. Skvortsova, the vaccine will be used initially for colorectal cancer. In parallel, FMBA is also completing the development of a vaccine against glioblastoma, one of the most malignant tumors, with barrier tumors located behind the blood-brain barrier in the brain structure, and special types of melanoma./.

(Vietnam News Agency/Vietnam+)

Source: https://www.vietnamplus.vn/nga-tuyen-bo-vaccine-chong-ung-thu-da-san-sang-su-dung-post1060330.vnp